Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Oseltamivir Phosphate for Oral Suspension, 6 mg ...
SAN FRANCISCO--(BUSINESS WIRE)--Alembic, the leading holistic marketing attribution platform for enterprises, today announced it received $14 million in series A funding. The round was led by WndrCo, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results